Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Aminopyrimidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110655491B reveals a safer, high-yield route for 2-aminopyrimidine-5-carboxylate, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109485608B details high-yield synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable high-purity processes.
Novel selective PLK1 inhibitor synthesis with high metabolic stability. Reduces toxicity for oncology drug development. Reliable pharmaceutical intermediates supplier.
Patent CN114907273B reveals a novel 4A molecular sieve method for high-yield 2-aminopyrimidine synthesis, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel organosilane reduction method for Ticagrelor intermediate ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.
Novel amination process for high-purity pyrimidine intermediates. Reduces waste and simplifies supply chain for pharmaceutical manufacturing partners globally.
Novel green synthesis of 4,6-dichloro-2-(propylthio)-5-aminopyrimidine avoiding hazardous diazotization. Cost-effective API intermediate manufacturing solution.
Patent CN103923020A reveals a cost-effective synthesis route for Ticagrelor intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chemistry.
Patent CN103965118A details a novel synthesis of pinanyl-2-aminopyrimidine compounds from turpentine. This report analyzes technical feasibility and supply chain advantages for pharmaceutical manufacturers.
Novel FeCl3-catalyzed reduction method for high-purity 2-aminopyrimidine compounds, eliminating toxic iron sludge and difficult impurities for scalable API manufacturing.
Patent CN109053590B reveals a high-yield triphosgene route for 4,6-dichloro-2-aminopyrimidine, offering significant cost reduction and simplified purification for agrochemical manufacturing.
Novel 2-step synthesis of 2-chloro-5-aminopyrimidine from 5-nitrouracil offers high yield and cost reduction for pharmaceutical intermediates manufacturing.
Novel patent CN104725322B details efficient 2-aminopyrimidine synthesis. Offers high yield and cost advantages for supply chain stability and commercial scalability in drug manufacturing.
Patent CN109081856B reveals a high-yield route for 4-ferrocenyl-6-aryl-2-aminopyrimidines, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN101003511B details a novel synthesis route for Abacavir intermediates offering simplified operations and enhanced supply chain reliability for global pharmaceutical manufacturing.
Advanced purification technology for 4,6-dichloro-2-(thiopropyl)-5-aminopyrimidine ensures >99.5% purity. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN105085411A reveals a greener synthesis route for acyclovir intermediates offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102276537A details a streamlined 4-step synthesis for 2-cyano-5-aminopyrimidine. Discover cost-effective manufacturing and scalable supply chain solutions for this critical heterocyclic building block.
Novel iridium-catalyzed N-alkylation method for 2-(N-alkyl)aminopyrimidines using alcohols. High atom economy, water byproduct only. Ideal for pharma intermediates.
Solve hydrogenation and iron contamination issues in aminopyrimidine synthesis. Our CDMO expertise delivers high-yield, GMP-compliant production for non-small cell lung cancer therapeutics.